Aswan university hospitals
Aswān, Egypt
NCT Number: NCT07550751
To determine the optimal dosage of Melatonin for preoperative sedation in patients undergoing FESS.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Phase 4
Aswān, Egypt
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
comparison between placebo and different melatonin doses(3-5-10 mg)
Time frame: just before intravenous anesthetic induction and one hour after recovery
assess of sedation pre-induction of anesthesia and one hour after recovery
Time frame: Baseline one hour before surgery, just before induction of anaesthesia and one hour after recovery
Questionnaire assessment of anxiety
Time frame: Baseline and perioperative
Effect of preoperative different doses of melatonin on heart rate as a part of hemodynamic stability
Time frame: Baseline and perioperative
Effect of preoperative different doses of melatonin on blood pressure as a part of hemodynamic stability
Time frame: Baseline and perioperative
Effect of preoperative different doses of melatonin on oxygen saturation as a part of hemodynamic stability
Time frame: 1,2,4and6 hours postoperative
Assessment of the effect of melatonin on postoperative pain management
Aswan University Hospital
Other
Optimal Melatonin Dosage for Effective Sedation, Hemodynamic Stability and Pain Control in Functional Endoscopic Sinus Surgery (FESS)
Acronym: FESS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05628155
Atrophy, Clinical Trial
Rennes, France
View Trial DetailsNCT07081529
Clinical Trial, Dental Caries
View Trial DetailsNCT07017296
Clinical Trial
Pachuca, Hidalgo, Mexico
View Trial DetailsNCT06037603
Behavior, Brain Concussion
Las Vegas, Nevada, United States
View Trial Details